Credit: Sergey Nivens/Shutterstock.com
The median annual price of 13 new drugs approved this year by the U.S. Food and Drug Administration for chronic conditions is $257,000, according to a new analysis from Reuters. Additionally, seven other recently launched drugs are priced at more than $200,000 per year. By comparison, the median annual price for the first 30 drugs marketed through mid-July 2021 was $180,000, according to a Journal of the American Medical Association study.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
